| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/25/2007 | CN1327895C Method for preparing aftosa vaccine |
| 07/25/2007 | CN1327894C Nucleic acid encoding hyaluronan synthase and method of use |
| 07/25/2007 | CN101006100A Optimized dosing with anti-CD4 antibodies for tolerance induction in primates |
| 07/25/2007 | CN101005854A Method for augmenting B cell depletion |
| 07/25/2007 | CN101005760A A method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101002947A Target medicine used for treating bacteriosis, and its preparing method |
| 07/25/2007 | CN101002937A Recombinant His-IT-B7-H11gV tumor vaccine, and its preparing method |
| 07/25/2007 | CN101002936A Vaccine for preventing flavivirus infection |
| 07/25/2007 | CN101002727A Adjuvant for transcutaneous immunization |
| 07/24/2007 | US7247712 Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof |
| 07/24/2007 | US7247711 For therapy or reducing the symptoms of immune, neurological, and related disorders, such as, but not limited to, multiple sclerosis, rheumatoid arthritis, juvenile rheumatoid arthritis, systemic onset juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondilitis, gastric ulcer |
| 07/24/2007 | US7247703 Anticancer agents; protein complex |
| 07/24/2007 | US7247619 Modulate immunology response; isolation nucleic acids; induce immunology response; genetic engineering |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/24/2007 | US7247612 novel cell surface molecules of mammals |
| 07/24/2007 | US7247608 FGF homolog polypeptides |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247472 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/24/2007 | US7247453 Calcium binding recombinant antibody against protein C |
| 07/24/2007 | US7247447 Methods to obtain and use such proteins, antibodies, and inhibitory compounds; treating flea infestations in animals; biological pest control |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247441 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 07/24/2007 | US7247433 Low cost; simple; reduced lesion mass |
| 07/24/2007 | US7247310 Combination of a microparticle of a fragment of solidified, chemically fixed tumor tissues or cells, sized so to allow phagocytosis of the fragment; and a cytokine and/or a cytokine-inducing agent such as a granulocyte-macrophage-colony stimulating factor and/or interleukin-2 |
| 07/24/2007 | US7247309 Eimeria strain characterised in that it is tolerant for a first group of coccidiostatic drugs, sensitive to a second group of coccidiostatic drug and has a decreased proliferation capacity |
| 07/24/2007 | US7247308 Vaccine; polynucleotide; generating antibodies |
| 07/24/2007 | US7247307 Vaccines against Escherichia coli O157 infection |
| 07/24/2007 | US7247306 Bacteria strain and bacteriocin produced therefrom |
| 07/24/2007 | US7247305 Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 07/24/2007 | US7247304 Methods of treating using anti-IL-15 antibodies |
| 07/24/2007 | US7247303 Antibody that binds to phosphatidyl serine comprising a CDR of the monoclonal antibody 3G4 produced by hybridoma; anticarcinogenic, antitumor, and viricidal agents; angiogenesis inhibitors |
| 07/24/2007 | US7247302 Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2335851C Apparatus and methods for preparing an implantable graft |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/24/2007 | CA2162134C Hepatitis-c virus type 4,5 and 6 |
| 07/24/2007 | CA2121798C Novel cytokine |
| 07/24/2007 | CA2097019C Process for attenuated varicella zoster virus vaccine production |
| 07/24/2007 | CA1341536C Transforming growth factor peptides |
| 07/24/2007 | CA1341535C Transforming growth factor peptides |
| 07/23/2007 | CA2637947A1 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 07/19/2007 | WO2007082177A2 Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity |
| 07/19/2007 | WO2007082105A2 Chlamydia vaccine |
| 07/19/2007 | WO2007081938A2 Mannheimia haemolytica chimeric outer membrane protein plpe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever |
| 07/19/2007 | WO2007081896A2 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 07/19/2007 | WO2007081878A2 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells |
| 07/19/2007 | WO2007081716A2 Self-illuminating quantum dot systems and methods of use thereof |
| 07/19/2007 | WO2007081583A2 Anti-pneumococcal preparations and methods of use |
| 07/19/2007 | WO2007081365A2 Multiple antigenic agents and methods for using the same |
| 07/19/2007 | WO2007081288A1 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | WO2007081287A1 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 07/19/2007 | WO2007080977A1 Preventive or therapeutic agent and method for immune disease |
| 07/19/2007 | WO2007080392A2 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor |
| 07/19/2007 | WO2007080277A1 Method for preparing antibodies selective for activating fc receptors |
| 07/19/2007 | WO2007080129A1 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
| 07/19/2007 | WO2007079755A1 Reimmunization and antibody design |
| 07/19/2007 | WO2007079684A1 A mycobacterium tuberculosis fusion protein and uses thereof |
| 07/19/2007 | WO2007059203A3 Treating inflammatory disorders with antibodies to the alpha-7 nicotinic receptors |
| 07/19/2007 | WO2007050095A3 Improved vaccines and methods for using the same |
| 07/19/2007 | WO2007048086A9 Canine influenza virus and related compositions and methods of use |
| 07/19/2007 | WO2007047831A3 Functional influenza virus like particles (vlps) |
| 07/19/2007 | WO2007030637A8 Hiv gp120 crystal structure and its use to identify immunogens |
| 07/19/2007 | WO2007015174A3 Exosome-specific ligands, their preparartion and uses |
| 07/19/2007 | WO2006136448A3 Attenuated sars and use as a vaccine |
| 07/19/2007 | WO2006123155A3 Vaccine composition comprising b-subunit of e. coli heat toxin and an atigen and an adjuvant |
| 07/19/2007 | WO2006120038A3 Use of native peptides and their optimized derivatives for vaccination |
| 07/19/2007 | WO2006113703A8 Carboline derivatives useful in the treatment of cancer |
| 07/19/2007 | WO2006089121A3 Streptococcus iniae phosphoglucomutase is a virulence factor and target for vaccine development |
| 07/19/2007 | WO2006065867A3 Polymer-linked pseudomonas exotoxin immunotoxin |
| 07/19/2007 | WO2006065821A8 Improved dna immunization with recombinase/transposase |
| 07/19/2007 | WO2006050159A3 Methods of predicting responsiveness to treatment |
| 07/19/2007 | WO2005120546A3 Compositions and methods for topical diagnostic and therapeutic transport |
| 07/19/2007 | WO2005084184A3 Methods for enhancing learning and memory |
| 07/19/2007 | WO2003054144A8 Human ras interacting protein |
| 07/19/2007 | WO2003035847A3 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 07/19/2007 | US20070169207 Transgenic nonhuman animal having germ or somatic cell containing nucleic acid encoding human amyloid precursor protein including nucleotides encoding codon 670 and 671; diagnosing and/or predicting predisposition; drug screening |
| 07/19/2007 | US20070167644 Bifunctional energy-reversible acyl-compositions |
| 07/19/2007 | US20070167386 Remedy for cardiac failure containing ask1 inhibitor as active ingredient and method for screening the same |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166802 West nile vaccine |
| 07/19/2007 | US20070166784 Combination approaches for generating immune responses |
| 07/19/2007 | US20070166753 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy |
| 07/19/2007 | US20070166711 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166699 Combination of anti-hpv-16 and 18 antibodies and uses thereof |
| 07/19/2007 | US20070166388 Combinations and modes of administration of therapeutic agents and combination therapy |
| 07/19/2007 | US20070166384 Methods , composition and preparations for delivery of immune response modifiers |
| 07/19/2007 | US20070166377 Water solubility; silicones; vaccines |
| 07/19/2007 | US20070166368 Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 07/19/2007 | US20070166335 Allergy inhibitor compositions and kits and methods of using the same |
| 07/19/2007 | US20070166334 Coccidiosis Vaccines |
| 07/19/2007 | US20070166333 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations |
| 07/19/2007 | US20070166332 A di-chain loop region modification comprising a Clostridial toxin substrate cleavage site from a SNARE protein within the di-chain loop region that is proteolytically cleaved by the enzymatic domain of the recombinantly modified Clostridial toxin; cell expression includes single to di-chain conversion |
| 07/19/2007 | US20070166331 Modified seb and prophylactics/remedies for immunopathy containing the same |
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |